Chat with GenHealth to automate any coding or chart task.
Name of the Condition
- Benign essential microscopic hematuria.
Summary
Benign essential microscopic hematuria is characterized by the presence of red blood cells in the urine, detectable only under a microscope, without an identifiable underlying cause after thorough evaluation. It is considered benign because it does not typically indicate a serious condition or progress to more severe disease. The condition is often discovered incidentally during routine urine testing and may persist over time without causing symptoms.
Causes
The exact cause of benign essential microscopic hematuria is not well understood, as no specific underlying pathology is identified despite comprehensive evaluation. It is thought to result from minor, non-pathological changes in the urinary tract or may represent a normal variant in some individuals. Unlike other forms of hematuria, no infection, stone, tumor, or structural abnormality is found to explain the blood in the urine.
Risk Factors
- Family history of benign essential microscopic hematuria.
- Certain demographic factors, such as age or gender, may be associated, though specific risks are not well defined.
- No clear modifiable risk factors have been established, as the condition is idiopathic.
Symptoms
- Typically asymptomatic; blood in the urine is not visible to the naked eye.
- May be discovered during routine urinalysis or health screenings.
- No associated urinary symptoms (e.g., pain, frequency, or urgency) are present.
Diagnosis
Diagnosis involves ruling out other causes of microscopic hematuria through a thorough evaluation. This includes a detailed medical history, physical examination, and repeated urinalysis to confirm persistent blood in the urine. Further testing, such as imaging of the urinary tract (e.g., ultrasound or CT scan) and cystoscopy, is performed to exclude structural abnormalities, infections, or tumors. If no underlying cause is identified after these investigations, the condition is classified as benign essential microscopic hematuria.
Treatment Options
Treatment is generally not required, as the condition is benign and does not indicate a serious disease. Management focuses on monitoring and reassurance. In some cases, periodic follow-up urinalysis or imaging may be recommended to ensure no new abnormalities develop over time.
Prognosis and Follow-Up
The prognosis is excellent, as benign essential microscopic hematuria does not typically lead to kidney disease, cancer, or other complications. Most individuals remain asymptomatic, and the condition often persists without progression. Follow-up may involve periodic urine tests or imaging to monitor for any changes, though specific intervals depend on clinical judgment.
Complications
Complications are rare, as the condition is benign. However, if an underlying cause is missed or develops later, complications related to that condition (e.g., infection, obstruction, or malignancy) could occur. Regular monitoring helps mitigate this risk.
Lifestyle & Prevention
No specific lifestyle changes are known to prevent benign essential microscopic hematuria, as the cause is idiopathic. Maintaining overall urinary tract health through adequate hydration and avoiding irritants (e.g., certain medications or chemicals) may be advised, though evidence for prevention is limited.
When to Seek Professional Help
Seek medical evaluation if microscopic hematuria is first detected, to rule out other causes. Follow up with a healthcare provider if symptoms such as visible blood in the urine, pain, or changes in urinary habits develop, as these may indicate a different underlying condition.
Tips for Medical Coders
- Use R31.1 for cases where microscopic hematuria is confirmed, and thorough evaluation has excluded other causes (e.g., infection, stones, or malignancy).
- Document the absence of identifiable pathology and the benign nature of the condition to support the diagnosis.
- Ensure coding aligns with clinical findings; avoid using this code if an underlying cause is suspected or diagnosed.
Medical Policies and Guidelines
Related policies from health plans
R31.1 policy automation walkthrough
Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.